Detalles de la búsqueda
1.
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice.
Haematologica
; 108(8): 2192-2204, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546453
2.
Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe.
Future Oncol
; 19(31): 2103-2121, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37706245
3.
Model-guided combinatorial optimization of complex synthetic gene networks.
Mol Syst Biol
; 12(12): 899, 2016 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28031353
4.
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry.
Cancers (Basel)
; 13(23)2021 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885106
5.
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.
Hemasphere
; 6(12): e813, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479545
6.
Precision multidimensional assay for high-throughput microRNA drug discovery.
Nat Commun
; 7: 10709, 2016 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26880188
7.
Synthetic Biology Platform for Sensing and Integrating Endogenous Transcriptional Inputs in Mammalian Cells.
Cell Rep
; 16(9): 2525-37, 2016 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27545896
8.
Highly modular bow-tie gene circuits with programmable dynamic behaviour.
Nat Commun
; 5: 4729, 2014 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25311543
Resultados
1 -
8
de 8
1
Próxima >
>>